Parameter
| Biomarker | Melatonin | Full name | Melatonin | Molecular Type | Hormone |
|---|---|---|---|---|---|
| Molecular Formula | C13H16N2O2 | Molecular Weight | 232.28 g/mol | Core Functional Dimensions | Monitoring, Prognosis |
| Disease | Schizophrenia | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Saliva/Plasma (ELISA, LC-MS/MS) | ||
| Pathobiological Mechanisms | Circadian rhythm disturbance; decreased secretion weakens anti-inflammatory and neuroprotective effects. | ||||
| Clinical Availability Status | Research Stage | ||||
| Notes and Dynamics | Decreased nighttime levels are associated with comorbid insomnia; exogenous supplementation can improve sleep quality. | ||||